Characterization of nanoparticle delivery in microcirculation using a microfluidic device

Microvascular Research

Volumn 94, Issue , 2014, Pages 17-27

  Thomas, Antony ^a   Tan, Jifu ^b   Liu, Yaling ^a,b  

^a LEHIGH UNIVERSITY   (United States)

^b Lehigh University   (United States)

Author keywords

Bifurcation region; Microcirculation; Microfluidic chip; Microvasculature; Nanoparticle; Particle distribution; Red blood cells; Shear rate

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; NANOPARTICLE; ANTIBODY; DIMETICONE; DRUG CARRIER; POLYSTYRENE DERIVATIVE;

ARTICLE; BINDING KINETICS; BLOOD CELL; BLOOD FLOW; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; DENSITY; DRUG DELIVERY SYSTEM; ERYTHROCYTE; GENERAL MEDICAL DEVICE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROCIRCULATION; MICROFLUIDIC CHIP; MICROFLUIDIC DEVICE; PARTICLE ANTIBODY DENSITY; PARTICLE BINDING DENSITY; PARTICLE SIZE; PRIORITY JOURNAL; SHEAR RATE; VESSEL GEOMETRY; ANIMAL; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DEVICES; GOAT; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; MICROVASCULATURE; MOUSE; PHYSIOLOGY; PROCEDURES; SHEAR STRENGTH;

ANIMALS; ANTIBODIES; DIMETHYLPOLYSILOXANES; DRUG CARRIERS; ERYTHROCYTES; GOATS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICROCIRCULATION; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROFLUIDICS; MICROSCOPY, CONFOCAL; MICROVESSELS; NANOPARTICLES; PARTICLE SIZE; POLYSTYRENES; SHEAR STRENGTH;

EID: 84904617889     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2014.04.008     Document Type: Article

References (71)

1. Aarts P., Heethaar R., Sixma J. Red blood cell deformability influences platelets-vessel wall interaction in flowing blood. Blood 1984, 64(6):1228-1233.
2. Abbitt K.B., Nash G.B. Rheological properties of the blood influencing selectin-mediated adhesion of flowing leukocytes. Am. J. Physiol. Heart Circ. Physiol. 2003, 285(1):H229-H240.
3. Allen T.M., Cullis P.R. Liposomal drug delivery systems: From concept to clinical applications. Adv. Drug Deliv. Rev. 2013, 65(1):36-48.
4. Blankenberg S., et al. Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease. Circulation 2001, 104(12):1336-1342.
5. Calderon A.J., Muzykantov V., Muro S., Eckmann D.M. Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. Biorheology 2009, 46:323-341.
6. Charoenphol P., Huang R.B., Eniola-Adefeso O. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials 2010, 31(6):1392-1402.
7. Chau L., Doran M., Cooper-White J. A novel multishear microdevice for studying cell mechanics. Lab Chip 2009, 9(13):1897-1902.
8. Cho K., et al. Therapeutic Nanoparticles for Drug Delivery in Cancer. Clin. Cancer Res. 2008, 14(5):1310-1316.
9. Danhier F., et al. PLGA-based nanoparticles: An overview of biomedical applications. J. Control. Release 2012, 161(2):505-522.
10. Decuzzi P., Gentile F., Granaldi A., Curcio A., Causa F., Indolfi C., Netti P., Ferrari M. Flow chamber analysis of size effects in the adhesion of spherical particles. Int. J. Nanomedicine 2007, 2(4):689-696.
11. Eckstein E.C., Tilles A.W., Millero F.J. Conditions for the occurrence of large near-wall excesses of small particles during blood flow. Microvasc. Res. 1988, 36(1):31-39.
12. Fåhræus R., Lindqvist T. The Viscosity of the blood in narrow capillary tubes. Am. J. Physiol. Leg. Content 1931, 96(3):562-568.
13. Fenton B., Wilson D., Cokelet G. Analysis of the effects of measured white blood cell entrance times on hemodynamics in a computer model of a microvascular bed. Pflugers Arch. 1985, 403(4):396-401.
14. Fung Y.-C. Stochastic flow in capillary blood vessels. Microvasc. Res. 1973, 5(1):34-48.
15. Gaehtgens P., Meiselman H.J., Wayland H. Velocity profiles of human blood at normal and reduced hematocrit in glass tubes up to 130μ diameter. Microvasc. Res. 1970, 2(1):13-23.
16. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today 1993, 14(10):506-512.
17. Gentile F., et al. The margination propensity of spherical particles for vascular targeting in the microcirculation. J. Nanobiotechnol. 2008, 6(1):9.
18. Gimbrone M.A., Nagel T., Topper J.N. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J. Clin. Invest. 1997, 99(8):1809-1813.
19. Goldman A.J., Cox R.G., Brenner H. Slow viscous motion of a sphere parallel to a plane wall-II Couette flow. Chem. Eng. Sci. 1967, 22(4):653-660.
20. Goldsmith Harry L. The microcirculatory society Eugene M. Landis award lecture: The microrheology of human blood. Microvasc. Res. 1986, 31(2):121-142.
21. Goldsmith H.L., Mason S.G. Particle motions in sheared suspensions XIII. The spin and rotation of disks. J. Fluid Mech. 1962, 12(01):88-96.
22. Goldsmith H.L., Mason S.G. The microrheology of dispersions. Rheology, Theory, and Applications 1967, 4:85-250. Academic Press, New York. F.R. Eirich (Ed.).
23. Haun J.B., Hammer D.A. Quantifying Nanoparticle Adhesion Mediated by Specific Molecular Interactions. Langmuir 2008, 24(16):8821-8832.
24. Hiroaki Tanaka, Masakazu Yashiro, Sunami Takeshi, Ohira Masaichi, Hirakawa K., Chung Y.S. Lipid-mediated gene transfection of intercellular adhesion molecule-1 suppresses the peritoneal metastasis of gastric carcinoma. Int. J. Mol. Med. 2002, 10(5).
25. Ji Ho Seong, J.Y.L., S.J.L. In-vitro study on the hemorheological characteristics of chicken blood in microcirculation. Rheol. J. 2007, 19:89-95.
26. Kanwar J.R., et al. Requirements for ICAM-1 immunogene therapy of lymphoma. Cancer Gene Ther. 2003, 10(6):468-476.
27. Kim S., et al. The cell-free layer in microvascular blood flow. Biorheology 2009, 46(3):181-189.
28. Kona S., et al. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int. J. Pharm. 2012, 423(2):516-524.
29. Lamberti G., et al. Adhesive interaction of functionalized particles and endothelium in idealized microvascular networks. Microvasc. Res. 2013, 89:107-114.
30. Lammers T., et al. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. J. Control. Release 2012, 161(2):175-187.
31. Langer R. Drug Delivery and Targeting. Nature 1998, 392:9-10.
32. Lee J., Lee S. Murray's law and the bifurcation angle in the arterial micro-circulation system and their application to the design of microfluidics. Microfluid. Nanofluid. 2010, 8(1):85-95.
33. Lew H.S., Fung Y.C. Entry flow into blood vessels at arbitrary Reynolds number. J. Biomech. 1970, 3(1):23-38.
34. Light Greg, S.S., Park Eun-Jung, Drane Denise Student understanding of "surface-area-to-volume ratio" and its relationship to property change in the nano-science engineering context 2010.
35. Liu Y., Shah S., Tan J. Computational Modeling of Nanoparticle Targeted Drug Delivery. Rev. Nanosci. Nanotechnol. 2012, 1(1):66-83.
36. Maeda N., et al. Erythrocyte flow and elasticity of microvessels evaluated by marginal cell-free layer and flow resistance. Am. J. Physiol. Heart Circ. Physiol. 1996, 271(6):H2454-H2461.
37. Mayrovitz H.N., Tuma R.F., Wiedeman M.P. Relationship between microvascular blood velocity and pressure distribution. Am. J. Physiol. Heart Circ. Physiol. 1977, 232(4):H400-H405.
38. McDonald J.C., Whitesides G.M. Poly(dimethylsiloxane) as a Material for Fabricating Microfluidic Devices. Acc. Chem. Res. 2002, 35(7):491-499.
39. McHedlishvili G., Maeda N. Blood Flow Structure Related to Red Cell Flow: Determinant of Blood Fluidity in Narrow Microvessels. Jpn. J. Physiol. 2001, 51(1):19-30.
40. Melder R.J., et al. Selectin- and integrin-mediated T-lymphocyte rolling and arrest on TNF-alpha-activated endothelium: augmentation by erythrocytes. Biophys. J. 1995, 69(5):2131-2138.
41. Min J.-K., et al. TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial Cells. J. Immunol. 2005, 175(1):531-540.
42. Mourya V.K., Inamdar N. Trimethyl chitosan and its applications in drug delivery. J. Mater. Sci. Mater. Med. 2009, 20(5):1057-1079.
43. Nagaoka T., Yoshida A. Noninvasive Evaluation of Wall Shear Stress on Retinal Microcirculation in Humans. Invest. Ophthalmol. Vis. Sci. 2006, 47(3):1113-1119.
44. Namdee K., et al. Margination Propensity of Vascular-Targeted Spheres from Blood Flow in a Microfluidic Model of Human Microvessels. Langmuir 2013, 29(8):2530-2535.
45. Nanne E.E., Aucoin C.P., Leonard E.F. Shear Rate and Hematocrit Effects on the Apparent Diffusivity of Urea in Suspensions of Bovine Erythrocytes. ASAIO J. 2010, 56(3):151-156. 10.1097/MAT.0b013e3181d4ed0f.
46. Nigro P., Abe J.-i., Berk B.C. Flow Shear Stress and Atherosclerosis: A Matter of Site Specificity. Antioxid. Redox Signal. 2011, 15(5):1405-1414.
47. Orcutt K.D., et al. Effect of small-molecule-binding affinity on tumor uptake in vivo: A systematic study using a pretargeted bispecific antibody. Mol. Cancer Ther. 2012, 11(6):1365-1372.
48. Packhaeuser C.B., et al. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 2004, 58(2):445-455.
49. Park J.W., et al. Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery. Clin. Cancer Res. 2002, 8(4):1172-1181.
50. Popel A.S., Johnson P.C. Microcirculation and hemorheology. Annu. Rev. Fluid Mech. 2005, 37:43-69.
51. Prabhakarpandian B., et al. Bifurcations: Focal Points of Particle Adhesion in Microvascular Networks. Microcirculation 2011, 18(5):380-389.
52. Pries A.R., Secomb T.W., Gaehtgens P. Structure and hemodynamics of microvascular networks: heterogeneity and correlations. Am. J. Physiol. Heart Circ. Physiol. 1995, 269(5):H1713-H1722.
53. Pries A.R., Secomb T.W., Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc. Res. 1996, 32(4):654-667.
54. Rakesh K.J., Triantafyllos S. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7(11):653-664.
55. Reinke W., Johnson P., Gaehtgens P. Effect of shear rate variation on apparent viscosity of human blood in tubes of 29 to 94 microns diameter. Circ. Res. 1986, 59(2):124-132.
56. Rosenblum William I. Ratio of red cell velocities near the vessel wall to velocities at the vessel center in cerebral microcirculation, and an apparent effect of blood viscosity on this ratio. Microvasc. Res. 1972, 4(1):98-101.
57. Segré G., Silberberg A. Behaviour of macroscopic rigid spheres in Poiseuille flow Part 2. Experimental results and interpretation. J. Fluid Mech. 1962, 14(01):136-157.
58. Shah S., et al. Modeling Particle Shape-Dependent Dynamics in Nanomedicine. J. Nanosci. Nanotechnol. 2011, 11(2):919-928.
59. Shinde Patil V.R., Campbell C.J., Yun Y.H., Slack S.M., Goetz D.J. Particle diameter influences adhesion under flow. Biophys. J. 2001, 80(4):1733-1743.
60. Singh R., Lillard J.W. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009, 86(3):215-223.
61. Son Y. Determination of shear viscosity and shear rate from pressure drop and flow rate relationship in a rectangular channel. Polymer 2007, 48(2):632-637.
62. Suri S., Fenniri H., Singh B. Nanotechnology-based drug delivery systems. J. Occup. Med. Toxicol. 2007, 2(1):16.
63. Tan J., Thomas A., Liu Y. Influence of red blood cells on nanoparticle targeted delivery in microcirculation. Soft Matter 2012, 8(6):1934-1946.
64. Tan J., et al. The influence of size, shape and vessel geometry on nanoparticle distribution. Microfluid. Nanofluid. 2013, 14(1-2):77-87.
65. Tan J., et al. Coupled particulate and continuum model for nanoparticle targeted delivery. Comput. Struct. 2013, 122(0):128-134.
66. Torchilin V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 2006, 58(14):1532-1555.
67. Yang B.H., et al. Migration of a sphere in tube flow. J. Fluid Mech. 2005, 540:109-131.
68. Yasuhiko Sugii, Nishio Shigeru, Okamoto Koji In vivo PIV measurement of red blood cell velocity field in microvessels considering mesentery motion. Physiol. Meas. 2002, 23(2).
69. Yen R.T., Fung Y.C. Effect of velocity of distribution on red cell distribution in capillary blood vessels. Am. J. Physiol. 1978, 09:H251-H257.
70. Zhai Y., et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 1998, 102(6):1142-1151.
71. Zhang Z., Kleinstreuer C., Donohue J.F., Kim C.S. Comparison of micro- and nano-size particle depositions in a human upper airway model. J. Aerosol Sci. 2005, 36:211-233.